Enhancing Equity in Non-Melanoma Skin Cancer: Incorporating the Latest Developments in Rural and Underserved Communities - Resistance, Sequencing, and Optimal Treatment Duration

2026
Project ECHO
Resistance
Sequencing
and Optimal Treatment Duration
CME
In this Project ECHO, we discuss Resistance, Sequencing, and Optimal Treatment Duration for high-risk Non-Melanoma Skin Cancer
Author

David M. Miller

Published

April 8, 2026

Event

RME Collaborative Oncology Congress- NMSC Project ECHO

Overview & Learning Objectives

  • Integrate interprofessional strategies to optimize management and outcomes of patients with non-melanoma skin cancer, particularly in rural and underserved communities